DUSTIN DEFRANCISIS: Open Payments
NPI 1073169595 · CLARION, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 40 payments from 12 companies in 2025. Trend: 2023 $527 · 2024 $764 · 2025 $697
Food & beverage: $697
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $156 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $116 |
| Novo Nordisk Inc | 3 | $75 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| GlaxoSmithKline, LLC. | 3 | $64 |
| Lilly USA, LLC | 3 | $61 |
| PFIZER INC. | 3 | $52 |
| Exact Sciences Corporation | 2 | $36 |
| ABBVIE INC. | 1 | $19 |
| Dexcom, Inc. | 1 | $18 |
Products named: OTEZLA, JARDIANCE, TRELEGY ELLIPTA, EVENITY, MOUNJARO, Cologuard Collection Kit, AIRSUPRA, Wegovy.
Industry payments across PA — which companies pay providers there.
